Recent Advances in Well-Designed Therapeutic Nanosystems for the Pancreatic Ductal Adenocarcinoma Treatment Dilemma

Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant tumor with an extremely poor prognosis and low survival rate. Due to its inconspicuous symptoms, PDAC is difficult to diagnose early. Most patients are diagnosed in the middle and late stages, losing the opportunity for surgery. Chemother...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xiao-Yan, Lu, Yuan-Fei, Xu, Jian-Xia, Du, Yong-Zhong, Yu, Ri-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9920782/
https://www.ncbi.nlm.nih.gov/pubmed/36771172
http://dx.doi.org/10.3390/molecules28031506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9920782/
https://www.ncbi.nlm.nih.gov/pubmed/36771172
http://dx.doi.org/10.3390/molecules28031506

Ejemplares similares